Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Synovial fibroblasts in rheumatoid arthritis (RAFLS) exhibit a pathological aberration of glycolysis and glutaminolysis. Henceforth, we aimed to investigate if dual inhibition of these pathways by phytobiological compound c28MS has the potential of synergistic therapy for arthritis by targeting both glucose and glutamine metabolism.
The presence...
Alternative Titles
Full title
Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_af32fe3ff392445c91651d974582a84f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_af32fe3ff392445c91651d974582a84f
Other Identifiers
ISSN
1478-6362,1478-6354
E-ISSN
1478-6362
DOI
10.1186/s13075-023-03161-0
